CVE-2026-126446
Awaiting Analysis Awaiting Analysis - Queue

OpenEMR Missing Authorization in Destroyed Drugs Report

Vulnerability report for CVE-2026-126446, including description, CVSS score, EPSS score, affected products, exploitability, helpful resources, and attack-flow context.

Publication date: 2026-11-13

Last updated on: 2026-11-13

Assigner: VulnCheck

Description

OpenEMR before 8.5.0 contains a missing authorization vulnerability that allows any authenticated core user to retrieve destroyed-drug records because destroyed_drugs_report.php lacks the admin/drugs or inventory/reporting ACL check. Attackers can submit the report refresh form with a chosen date range to obtain drug names, NDC, lots, quantities, destruction methods, witnesses, and notes.

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published
2026-11-13
Last Modified
2026-11-13
Generated
2026-11-13
AI Q&A
2026-11-13
EPSS Evaluated
N/A
NVD
EUVD

Affected Vendors & Products

Showing 1 associated CPE
Vendor Product Version / Range
openemr openemr to 8.5.0 (exc)

Helpful Resources

Exploitability

CWE
CWE Icon
KEV
KEV Icon
CWE ID Description
CWE-862 The product does not perform an authorization check when an actor attempts to access a resource or perform an action.

Attack-Flow Graph

AI Quick Actions

Instant insights powered by AI
Executive Summary

OpenEMR before version 8.5.0 has a missing authorization vulnerability in destroyed_drugs_report.php. This flaw allows any authenticated core user to access destroyed-drug records without proper admin or inventory reporting permissions. Attackers can exploit this by submitting a report refresh form with a chosen date range to retrieve sensitive drug information.

Detection Guidance

Check OpenEMR logs for unauthorized access to destroyed_drugs_report.php. Monitor network traffic for repeated requests to this endpoint with varying date ranges. Review user activity logs for core users accessing drug inventory reports outside normal workflows.

Impact Analysis

This vulnerability could allow unauthorized users to view confidential drug destruction records, including drug names, NDC codes, lot numbers, quantities, destruction methods, witnesses, and notes. This may lead to data breaches, unauthorized disclosure of sensitive information, or compliance violations depending on the organization's policies.

Compliance Impact

This vulnerability could violate compliance with regulations like HIPAA or GDPR by exposing protected health information or personal data without proper authorization. Organizations handling such data may face legal penalties, reputational damage, or loss of trust due to unauthorized access to sensitive records.

Mitigation Strategies

Upgrade OpenEMR to version 8.5.0 or later. Apply ACL checks to destroyed_drugs_report.php to restrict access to admin/drugs or inventory/reporting roles. Review and revoke any unauthorized user permissions for drug inventory access.

Chat Assistant

Ask questions about this CVE
Hi! I’m here to help you understand CVE-2026-126446. Ask me anything about the vulnerability, its impact, or mitigation strategies.
0/70

EPSS Chart

Security Radar

News mentioning this vulnerability
Loading related security news...